Teligent Inc (TLGT) Return on Equity ROE from the second quarter 2021 to second quarter 2020 and annually, average high and low, overall ranking from Jun 30 2021 to Jun 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Teligent Inc   (NASDAQ: TLGT)

Teligent Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Teligent Inc in the second quarter 2021?
Due to the lack of equity, it was not possible to calculate Teligent Inc 's return on equity (ROE) in its second quarter 2021

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -92 -93 -122 -47 -54
Return On Equity (TTM) - - - - -
TLGT's Total Ranking # # # # #
Equity (TTM) in Millions -59 -48 -110 -40 -38
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to TLGT Management Effectiveness >> TLGT's 5 Years Annual ROE >> Compare TLGT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





TLGT Annual Return On Equity (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions -110 -5 18 45 57
Y / Y Equity Change - - -58.84 % -21.02 % -15.12 %
Net Income in Millions -122 -25 -36 -15 -12
Y / Y Net Income Change - - - - -
Return On Equity - - -196.82 % -33.94 % -21.15 %

Back to TLGT Management Effectiveness >> TLGT's 5 Years Annual ROE >> Compare TLGT ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TLGT's' Return on Equity at Yahoo Finance
TLGT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TLGT's Competitors
Subscribers only: Roe for Teligent Inc 's Suppliers
Subscribers only: Return On Equity for TLGT's Customers




Companies with similar Return On Equity at Jun 30 2021, within Healthcare Sector ROE
Waters Corporation  383.01 %
Caremax Inc   356.96 %
Ironwood Pharmaceuticals inc   294.78 %
Hca Healthcare Inc   270.21 %
Strata Critical Medical Inc   239.76 %
Mettler toledo International Inc   230.70 %
Halozyme Therapeutics Inc   209.18 %
Vyne Therapeutics Inc   138.73 %
Agios Pharmaceuticals Inc   129.96 %
Idexx Laboratories Inc  115.33 %
Molecular Templates Inc   107.63 %
Tenet Healthcare Corp  100.88 %
Eli Lilly And Company  98.77 %
Reflect Scientific Inc  96.43 %
Adicet Bio Inc   95.32 %
Ovid Therapeutics Inc   91.02 %
Uniqure N v   90.98 %
Retractable Technologies Inc  89.38 %
Vaso Corporation  88.19 %
Moderna Inc   88.13 %
Orgenesis Inc   83.90 %
Integrated Biopharma Inc  80.87 %
Inmed Pharmaceuticals Inc  79.88 %
Fulgent Genetics Inc   79.61 %
Dyne Therapeutics Inc   76.74 %
Talkspace Inc   75.19 %
Quidelortho Corp  70.79 %
Davita Inc   70.43 %
Semler Scientific inc   68.78 %
Glucotrack Inc   67.06 %

Date modified: 2026-09-08T15:10:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.